89 related articles for article (PubMed ID: 28923690)
1. Optimization of media components for production of antimicrobial compound by Brevibacillus brevis EGS9 isolated from mangrove ecosystem.
T A; P SK
J Microbiol Methods; 2017 Nov; 142():83-89. PubMed ID: 28923690
[TBL] [Abstract][Full Text] [Related]
2. Isolation, structure elucidation and anticancer activity from Brevibacillus brevis EGS 9 that combats Multi Drug Resistant actinobacteria.
Arumugam T; Senthil Kumar P; Hemavathy RV; Swetha V; Karishma Sri R
Microb Pathog; 2018 Feb; 115():146-153. PubMed ID: 29278781
[TBL] [Abstract][Full Text] [Related]
3. HPTLC fingerprint profile, in vitro antioxidant and evaluation of antimicrobial compound produced from Brevibacillus brevis-EGS9 against multidrug resistant Staphylococcus aureus.
Arumugam T; Senthil Kumar P; Gopinath KP
Microb Pathog; 2017 Jan; 102():166-172. PubMed ID: 27939872
[TBL] [Abstract][Full Text] [Related]
4. Identification of ethylparaben as the antimicrobial substance produced by Brevibacillus brevis FJAT-0809-GLX.
Jianmei C; Bo L; Zheng C; Huai S; Guohong L; Cibin G
Microbiol Res; 2015 Mar; 172():48-56. PubMed ID: 25542595
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of edeine production in Brevibacillus brevis X23 via in situ promoter engineering.
Liu Q; Zhang L; Wang Y; Zhang C; Liu T; Duan C; Bian X; Guo Z; Long Q; Tang Y; Du J; Liu A; Dai L; Li D; Chen W
Microb Biotechnol; 2022 Feb; 15(2):577-589. PubMed ID: 34310825
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial peptides produced by Brevibacillus spp.: structure, classification and bioactivity: a mini review.
Yang X; Yousef AE
World J Microbiol Biotechnol; 2018 Mar; 34(4):57. PubMed ID: 29594558
[TBL] [Abstract][Full Text] [Related]
7. Siderophore Production by Rhizosphere Biological Control Bacteria
Sheng MM; Jia HK; Zhang GY; Zeng LN; Zhang TT; Long YH; Lan J; Hu ZQ; Zeng Z; Wang B; Liu HM
J Microbiol Biotechnol; 2020 May; 30(5):689-699. PubMed ID: 32482934
[No Abstract] [Full Text] [Related]
8. Triphenyltin biodegradation and intracellular material release by Brevibacillus brevis.
Ye J; Zhao H; Yin H; Peng H; Tang L; Gao J; Ma Y
Chemosphere; 2014 Jun; 105():62-7. PubMed ID: 24388446
[TBL] [Abstract][Full Text] [Related]
9. Self resistance to the atypical cationic antimicrobial peptide edeine of Brevibacillus brevis Vm4 by the N-acetyltransferase EdeQ.
Westman EL; Yan M; Waglechner N; Koteva K; Wright GD
Chem Biol; 2013 Aug; 20(8):983-90. PubMed ID: 23891151
[TBL] [Abstract][Full Text] [Related]
10. Screening of Actinomycetes from mangrove ecosystem for L-asparaginase activity and optimization by response surface methodology.
Usha R; Mala KK; Venil CK; Palaniswamy M
Pol J Microbiol; 2011; 60(3):213-21. PubMed ID: 22184928
[TBL] [Abstract][Full Text] [Related]
11. Tostadin, a novel antibacterial peptide from an antagonistic microorganism Brevibacillus brevis XDH.
Song Z; Liu Q; Guo H; Ju R; Zhao Y; Li J; Liu X
Bioresour Technol; 2012 May; 111():504-6. PubMed ID: 22391587
[TBL] [Abstract][Full Text] [Related]
12. [Isolation of an effective benzo [a] pyrene degrading strain and its degradation characteristics].
Cai H; Yin H; Ye JS; Chang JJ; Peng H; Zhang N; He BY
Huan Jing Ke Xue; 2013 May; 34(5):1937-44. PubMed ID: 23914551
[TBL] [Abstract][Full Text] [Related]
13. An economic approach for L-(+) lactic acid fermentation by Lactobacillus amylophilus GV6 using inexpensive carbon and nitrogen sources.
Altaf M; Venkateshwar M; Srijana M; Reddy G
J Appl Microbiol; 2007 Aug; 103(2):372-80. PubMed ID: 17650197
[TBL] [Abstract][Full Text] [Related]
14. Optimization of carbon and nitrogen sources and growth factors for the production of an aquaculture probiotic (Pseudomonas MCCB 103) using response surface methodology.
Preetha R; Jayaprakash NS; Philip R; Bright Singh IS
J Appl Microbiol; 2007 Apr; 102(4):1043-51. PubMed ID: 17381748
[TBL] [Abstract][Full Text] [Related]
15. Biosorption and biodegradation of pyrene by Brevibacillus brevis and cellular responses to pyrene treatment.
Liao L; Chen S; Peng H; Yin H; Ye J; Liu Z; Dang Z; Liu Z
Ecotoxicol Environ Saf; 2015 May; 115():166-73. PubMed ID: 25700095
[TBL] [Abstract][Full Text] [Related]
16. Optimization and production of pyrrolidone antimicrobial agent from marine sponge-associated Streptomyces sp. MAPS15.
Sathiyanarayanan G; Gandhimathi R; Sabarathnam B; Seghal Kiran G; Selvin J
Bioprocess Biosyst Eng; 2014 Mar; 37(3):561-73. PubMed ID: 23917410
[TBL] [Abstract][Full Text] [Related]
17. Optimization of submerged culture requirements for the production of mycelial growth and exopolysaccharide by Cordyceps jiangxiensis JXPJ 0109.
Xiao JH; Chen DX; Liu JW; Liu ZL; Wan WH; Fang N; Xiao Y; Qi Y; Liang ZQ
J Appl Microbiol; 2004; 96(5):1105-16. PubMed ID: 15078528
[TBL] [Abstract][Full Text] [Related]
18. Improved antimicrobial compound production by a new isolate Streptomyces hygroscopicus MTCC 4003 using Plackett-Burman design and response Surface methodology.
Singh N; Rai V
Bioinformation; 2012; 8(21):1021-5. PubMed ID: 23275700
[TBL] [Abstract][Full Text] [Related]
19. Bioprospecting of Brevibacillus brevis isolated from soil.
Samrot AV; Prasad RJ; Rio AJ; Sneha SJ
Recent Pat Biotechnol; 2015; 9(1):42-9. PubMed ID: 26563812
[TBL] [Abstract][Full Text] [Related]
20. Selective medium based on tyrosine metabolism for the isolation and enumeration of Brevibacillus brevis (Bacillus brevis).
Edwards SG; Seddon B
Lett Appl Microbiol; 2000 Nov; 31(5):395-9. PubMed ID: 11069644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
